McLaughlin Gerald W.

CIK 00014954125 companiesTARPON SPRINGS, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001495412

Recent Transactions

37 trades

Award
Allarity Therapeutics, Inc.$ALLR
Common Stock
2026-01-28+45,000→ 70,000 total
Award
Allarity Therapeutics, Inc.$ALLR
Stock Options
2025-01-22+25,000→ 25,000 total
Award
Allarity Therapeutics, Inc.$ALLR
Stock Options
2025-01-22+25,000→ 25,000 total
Award
AYTU BIOPHARMA, INC$AYTU
Common Stock
2021-04-08+6,500→ 31,401 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−395,000→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−100,000→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Common Stock
2021-03-19−270,171→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−65,447→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−392,688→ 0 total
Disposition to Issuer
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-19−600,000→ 0 total
Tax Payment
Neos Therapeutics, Inc.
Common Stock
2021-03-02$0.84/sh−44,329→ 270,171 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2020-03-13+100,000→ 100,000 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2020-03-13+65,447→ 65,447 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2020-03-02+395,000→ 395,000 total
Award
Neos Therapeutics, Inc.
Common Stock
2020-03-02+290,000→ 314,500 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2019-03-01+523,583→ 523,583 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2019-03-01+392,688→ 392,688 total
Purchase
Neos Therapeutics, Inc.
Common Stock
2018-12-06$2.11/sh+17,097→ 24,500 total
Purchase
Neos Therapeutics, Inc.
Common Stock
2018-12-04$2.04/sh+7,403→ 7,403 total
Award
Neos Therapeutics, Inc.
Stock Option (Right to Buy)
2018-06-27+600,000→ 600,000 total
Award
Skye Bioscience, Inc.$SKYE
Common Stock
2015-10-20+30,000→ 61,250 total
Conversion
Skye Bioscience, Inc.$SKYE
Series A Preferred Stock
2015-08-20−10,000→ 0 total
Conversion
Skye Bioscience, Inc.$SKYE
Common Stock
2015-08-20+31,250→ 31,250 total
Purchase
Skye Bioscience, Inc.$SKYE
Series A Preferred Stock
2015-05-29$2.50/sh+10,000→ 10,000 total
Purchase
Skye Bioscience, Inc.$SKYE
Common Stock Warrant (Right to Buy)
2015-05-29+2,000→ 2,000 total
Award
Skye Bioscience, Inc.$SKYE
Stock Option (Right to Buy)
2014-12-04+20,000→ 20,000 total
Disposition from Tender
NUPATHE INC.
Common Stock
2014-02-21$6.80/sh−11,771→ 0 total
Disposition to Issuer
NUPATHE INC.
Stock option (right to buy)
2014-02-21$4.88/sh−5,988→ 0 total
Disposition to Issuer
NUPATHE INC.
Stock option (right to buy)
2014-02-21$5.36/sh−22,707→ 0 total
Disposition to Issuer
NUPATHE INC.
Common Stock
2014-02-21$6.80/sh−144,880→ 0 total
Disposition to Issuer
NUPATHE INC.
Stock option (right to buy)
2014-02-21$4.88/sh−57,054→ 0 total
Award
NUPATHE INC.
Common Stock
2013-01-17+125,000→ 156,651 total
Award
NUPATHE INC.
Common Stock
2013-01-07+8,109→ 8,109 total
Award
NUPATHE INC.
Common Stock
2013-01-07+23,542→ 31,651 total
Disposition to Issuer
NUPATHE INC.
Stock Option (Right to Buy)
2013-01-07−32,850→ 0 total
Disposition to Issuer
NUPATHE INC.
Stock Option (Right to Buy)
2013-01-07−16,219→ 0 total
Award
NUPATHE INC.
Stock Option (Right to Buy)
2012-03-08+32,850→ 32,850 total

Companies

Recent Filings

Address

C/O ALLARITY THERAPEUTICS, INC. 123 E TARPON AVE

TARPON SPRINGS, FL, 34689

View on SEC.gov